Beijing Kleb Pharmaceutical Development

Beijing Kleb Pharmaceutical Development is a China-based Contract Research Organization (CRO) that provides end-to-end clinical development and regulatory affairs services. Founded in 2005, the company specializes in navigating the complex NMPA regulatory environment for both domestic and international pharmaceutical and medical device clients. Their service portfolio includes Phase I-IV clinical trial management, site monitoring, data management, statistical analysis, and medical writing. Kleb Pharmaceutical is recognized for its expertise in accelerating market entry for innovative therapies within the Chinese healthcare market. The company maintains a strong presence in major Chinese biotech hubs to support multi-center clinical trials.